|
|||||
|
|
Topical treatment utilization for patients with atopic dermatitis in the United States,and budget impact analysis of crisaborole ointment, 2% |
|
| Authors: | Ryan Clark Duygu Bozkaya Mark Levenberg Steven Faulkner Timothy W Smith Robert A Gerber |
| Institution: | 1. Xcenda, Palm Harbor, FL, USA;2. ryan.clark@xcenda.com;4. Pfizer Inc., Collegeville, PA, USA;5. Pfizer Inc., New York, NY, USA;6. Pfizer Inc., Groton, CT, USA |
| Abstract: | |
| Keywords: | Crisaborole atopic dermatitis topical treatment cost budget impact topical corticosteroids topical calcineurin inhibitors treatment utilization |